Singapore Market Roundup (13-Feb-2026): StarHub's weak FY2026 outlook triggers DBS review, says
StarHub's weak FY2026 outlook leads to a DBS review; IFAST shares drop despite strong earnings. DBS, BofA, and UOB maintain 'buy' on Singtel.
249 Views
Singapore Market Roundup (12-Feb-2026): Citi keeps 'buy' on CLI, sets $3.40 target amid M&A
Citi keeps 'buy' on CLI with $3.40 TP; Lim & Tan rates Reclaims Global as 'buy' at 60c; Maybank raises Thomson Medical's TP due to higher Johor...
194 Views
Singapore Market Roundup (11-Feb-2026): Citi keeps 'sell' on SIA, raises TP to $6.38 due to yield.
Citi keeps 'sell' on SIA, raising TP to $6.38. uSMART rates Yeo Hiap Seng 'hold' with a TP of 64.3 cents. OCBC's Lim raises Boustead Singapore's...
1.1k Views
Singapore Market Roundup (03-Feb-2026): RHB increases Starhill Global REIT's target price to 66
RHB raises Starhill Global REIT's target price to 66 cents. DBS shows interest in Coliwoo's asset potential. Analysts upgrade CDLHT; Citi keeps...
199 Views
Singapore Market Roundup (02-Feb-2026): CDLHT upgraded post FY2025 results; Citi stays 'sell'.
Analysts upgrade CDLHT post strong FY2025 results; Citi keeps 'sell' on CDLHT. CGS starts Nam Cheong coverage, while Maybank maintains 'buy' on...
241 Views